This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Overall, HLTH 2024 is expected to be a thought-provoking and informative event that will shape the future of healthcare. Nelson Advisors work with HealthcareTechnology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value.
To unlock the full potential of care teams, we must have access to actionable, real-time data. Patients are still coming to their doctor’s appointments frustrated that their provider does not have their records from a recent urgent care visit, previous primarycare provider, or a specialist.
Whereas a traditional visit to the doctor can analyze one’s physical health in a fixed time, technology can gather data throughout a patient’s lived experiences, helping healthcare professionals understand patient backgrounds, experiences, and personal preferences on a deeper level. Tanja Dowe, CEO of Debiopharm Innovation Fund S.A.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Drug Development 
57 
Let's personalize your content